BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1348 related articles for article (PubMed ID: 9064949)

  • 1. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
    Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
    Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Am Coll Cardiol; 1996 Oct; 28(4):948-58. PubMed ID: 8837573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both.
    Arrighi JA; Ng CK; Dey HM; Wackers FJ; Soufer R
    Am J Cardiol; 1997 Oct; 80(8):1007-13. PubMed ID: 9352969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
    Lund GK; Freyhoff J; Schwaiger M; Lübeck M; Lund CH; Buchert R; Sheehan FH; Meinertz T; Nienaber CA
    Cardiology; 2002; 98(4):202-9. PubMed ID: 12566650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
    Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
    J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholds.
    Schneider CA; Voth E; Gawlich S; Baer FM; Horst M; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1998 Sep; 32(3):648-54. PubMed ID: 9741506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization.
    Koch KC; vom Dahl J; Wenderdel M; Nowak B; Schaefer WM; Sasse A; Stellbrink C; Buell U; Hanrath P
    J Am Coll Cardiol; 2001 Jul; 38(1):91-8. PubMed ID: 11451302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC; Mody FV; Hawkins RA; Nienaber CA; Phelps ME; Schelbert HR
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
    Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
    Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of myocardial viability in asymptomatic patients early after infarction with perfusion/metabolism single-photon-emission computed tomographic imaging and dobutamine echocardiography.
    Dangas G; Machac J; Goldman ME; Sharma SK; Shao JH; Cohen AM; Meraj P; Feldman D; Ambrose JA
    Coron Artery Dis; 2000 Jul; 11(5):409-14. PubMed ID: 10895407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of myocardial viability with (99m)Tc-sestamibi -gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty.
    Tzonevska A; Tzvetkov K; Dimitrova M; Piperkova E
    Hell J Nucl Med; 2005; 8(1):48-53. PubMed ID: 15886754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography.
    Fragasso G; Chierchia SL; Lucignani G; Landoni C; Conversano A; Gilardi MC; Colombo F; Rossetti C; Fazio F
    Am J Cardiol; 1993 Dec; 72(19):131G-139G. PubMed ID: 8279350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology].
    Z Kardiol; 1996 Jul; 85(7):453-68. PubMed ID: 8928543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.